Schmitt Sabrina, Johnson Theron S, Karakhanova Svetlana, Näher Helmut, Mahnke Karsten, Enk Alexander H
Department of Dermatology, University Hospital Heidelberg, Vosstrasse 11, Heidelberg, Germany.
Transplantation. 2009 Aug 15;88(3):411-6. doi: 10.1097/TP.0b013e3181aed927.
During extracorporeal photophoresis (ECP), peripheral blood mononuclear cells are treated with DNA-intercalating agents and irradiated with ultraviolet light. This procedure exerts immunosuppressive effects, most likely mediated by regulatory T cells (Treg). However, the underlying mechanisms are not clear yet. In our study, we investigated the effect of ECP on frequency and function of Treg in the peripheral blood of patients suffering from graft-versus-host disease.
Whole blood samples from graft-versus-host disease patients were taken before and after the ECP treatment on 2 consecutive days. Phenotypical analysis of changes in distinct leukocyte subsets within the peripheral blood of patients and healthy controls was performed by means of flow cytometry. Functional analysis of the Treg population after magnetic bead isolation was performed using conventional suppression assays, and adenosine was detected by means of high pressure liquid chromatography and Lanzetta assays.
We show that the frequency of CD4/CD25/FoxP3 Treg in the peripheral blood increases after each cycle of ECP and also in the course of treatment. The suppressive capacity of Treg after ECP was increased compared with that of Treg before ECP, although not reaching the suppression levels obtained with Treg from healthy controls. Furthermore, we show that ECP stimulates the CD39-mediated production of adenosine by Treg, which substantially reduces the T-cell proliferation in in vitro suppression assays.
Our data indicate that ECP stimulates the conversion of ATP to adenosine by the ectonucleotiodase CD39, which acts as a novel soluble immunosuppressive reagent mediating immunosuppression of Treg.
在体外光化学疗法(ECP)过程中,外周血单个核细胞用DNA嵌入剂处理并接受紫外线照射。该程序发挥免疫抑制作用,最有可能由调节性T细胞(Treg)介导。然而,其潜在机制尚不清楚。在我们的研究中,我们调查了ECP对移植物抗宿主病患者外周血中Treg频率和功能的影响。
连续两天在ECP治疗前后采集移植物抗宿主病患者的全血样本。通过流式细胞术对患者和健康对照外周血中不同白细胞亚群的变化进行表型分析。使用传统抑制试验对磁珠分离后的Treg群体进行功能分析,并通过高压液相色谱法和兰泽塔试验检测腺苷。
我们发现,在每个ECP周期后以及治疗过程中,外周血中CD4/CD25/FoxP3 Treg的频率都会增加。与ECP前的Treg相比,ECP后的Treg抑制能力有所提高,尽管未达到健康对照Treg的抑制水平。此外,我们发现ECP刺激Treg通过CD39介导产生腺苷,这在体外抑制试验中显著降低了T细胞增殖。
我们的数据表明,ECP刺激外切核苷酸酶CD39将ATP转化为腺苷,CD39作为一种新型可溶性免疫抑制试剂介导Treg的免疫抑制作用。